OUR STRENGTH

How we will find the cure.

Congratulations to the TBF 2021 Grant Recipients

After reviewing dozens of grant proposals, our TBF Scientific Advisory Board has awarded fellowships to the following top 2021 researchers.

TBF
2021 Grant
Recipients

Daniel Abravanel MD, PhD
Douglas Micalizzi MD, PhD
Rachna Malani MD
Jennifer Rosenbluth MD, PhD

The Terri Brodeur Breast Cancer Foundation Granting Process

Click here to download a PDF of the The Terri Brodeur Breast Cancer Foundation (TBBCF) 2021 Granting Process

Background

This background is intended to support PhD, MD/PhD and MD physician scientists at earlier stages of their careers to enable them to develop independent programs and compelling careers in breast cancer research. The foundation seeks to fund broadly the very best proposals across all relevant disciplines and as such focus areas can include basic, preclinical, clinical research and clinical care. The award period is two years with a 1-year interim renewal to occur upon successful completion of the year one research goals. Stipends are $50,000 per year, with the intention that all funds are strictly used for direct support of the grantee or their research program.

The foundation maintains the highest standards and thus no minimum quota of grants are made in any one year. However, given the outstanding quality of candidates requesting support since the founding of the Terri Brodeur Breast Cancer Foundation, the committee seeks to fund as many meritorious fellowships as is financially possible each year. As such, it is our expectation that the grant administrators and mentors at each institution proactively carry out prescreening of proposals or applicants as is appropriate. We ask that this occurs as an active process as it greatly enables the administration of the funds. We are happy to provide additional guidance on this last point as may be needed.

Awards

This awards is intended to support PhD, MD/PhD and MD physician scientists at earlier stages of their careers to enable them to develop independent programs and compelling careers in breast cancer research. The foundation seeks to fund broadly the very best proposals across all relevant disciplines and as such focus areas can include basic, preclinical, clinical research and clinical care. The award period is two years with a 1-year interim renewal to occur upon successful completion of the year one research goals. Stipends are $50,000 per year, with the intention that all funds are strictly used for direct support of the grantee or their research program.

The foundation maintains the highest standards and thus no minimum quota of grants are made in any one year. However, given the outstanding quality of candidates requesting support since the founding of the Terri Brodeur Breast Cancer Foundation, the committee seeks to fund as many meritorious fellowships as is financially possible each year. As such, it is our expectation that the grant administrators and mentors at each institution proactively carry out prescreening of proposals or applicants as is appropriate. We ask that this occurs as an active process as it greatly enables the administration of the funds. We are happy to provide additional guidance on this last point as may be needed.

Application process

This application process is intended to support PhD, MD/PhD and MD physician scientists at earlier stages of their careers to enable them to develop independent programs and compelling careers in breast cancer research. The foundation seeks to fund broadly the very best proposals across all relevant disciplines and as such focus areas can include basic, preclinical, clinical research and clinical care. The award period is two years with a 1-year interim renewal to occur upon successful completion of the year one research goals. Stipends are $50,000 per year, with the intention that all funds are strictly used for direct support of the grantee or their research program.

The foundation maintains the highest standards and thus no minimum quota of grants are made in any one year. However, given the outstanding quality of candidates requesting support since the founding of the Terri Brodeur Breast Cancer Foundation, the committee seeks to fund as many meritorious fellowships as is financially possible each year. As such, it is our expectation that the grant administrators and mentors at each institution proactively carry out prescreening of proposals or applicants as is appropriate. We ask that this occurs as an active process as it greatly enables the administration of the funds. We are happy to provide additional guidance on this last point as may be needed.

Sources of funds

This sources of funds process is intended to support PhD, MD/PhD and MD physician scientists at earlier stages of their careers to enable them to develop independent programs and compelling careers in breast cancer research. The foundation seeks to fund broadly the very best proposals across all relevant disciplines and as such focus areas can include basic, preclinical, clinical research and clinical care. The award period is two years with a 1-year interim renewal to occur upon successful completion of the year one research goals. Stipends are $50,000 per year, with the intention that all funds are strictly used for direct support of the grantee or their research program.

The foundation maintains the highest standards and thus no minimum quota of grants are made in any one year. However, given the outstanding quality of candidates requesting support since the founding of the Terri Brodeur Breast Cancer Foundation, the committee seeks to fund as many meritorious fellowships as is financially possible each year. As such, it is our expectation that the grant administrators and mentors at each institution proactively carry out prescreening of proposals or applicants as is appropriate. We ask that this occurs as an active process as it greatly enables the administration of the funds. We are happy to provide additional guidance on this last point as may be needed.

Deadlines

This deadlines of funds process is intended to support PhD, MD/PhD and MD physician scientists at earlier stages of their careers to enable them to develop independent programs and compelling careers in breast cancer research. The foundation seeks to fund broadly the very best proposals across all relevant disciplines and as such focus areas can include basic, preclinical, clinical research and clinical care. The award period is two years with a 1-year interim renewal to occur upon successful completion of the year one research goals. Stipends are $50,000 per year, with the intention that all funds are strictly used for direct support of the grantee or their research program.

The foundation maintains the highest standards and thus no minimum quota of grants are made in any one year. However, given the outstanding quality of candidates requesting support since the founding of the Terri Brodeur Breast Cancer Foundation, the committee seeks to fund as many meritorious fellowships as is financially possible each year. As such, it is our expectation that the grant administrators and mentors at each institution proactively carry out prescreening of proposals or applicants as is appropriate. We ask that this occurs as an active process as it greatly enables the administration of the funds. We are happy to provide additional guidance on this last point as may be needed.

Notifications of application receipt and review

This notifications of application receipt and review of funds process is intended to support PhD, MD/PhD and MD physician scientists at earlier stages of their careers to enable them to develop independent programs and compelling careers in breast cancer research. The foundation seeks to fund broadly the very best proposals across all relevant disciplines and as such focus areas can include basic, preclinical, clinical research and clinical care. The award period is two years with a 1-year interim renewal to occur upon successful completion of the year one research goals. Stipends are $50,000 per year, with the intention that all funds are strictly used for direct support of the grantee or their research program.

The foundation maintains the highest standards and thus no minimum quota of grants are made in any one year. However, given the outstanding quality of candidates requesting support since the founding of the Terri Brodeur Breast Cancer Foundation, the committee seeks to fund as many meritorious fellowships as is financially possible each year. As such, it is our expectation that the grant administrators and mentors at each institution proactively carry out prescreening of proposals or applicants as is appropriate. We ask that this occurs as an active process as it greatly enables the administration of the funds. We are happy to provide additional guidance on this last point as may be needed.

Publications and other research communications

This publications and other research communications is intended to support PhD, MD/PhD and MD physician scientists at earlier stages of their careers to enable them to develop independent programs and compelling careers in breast cancer research. The foundation seeks to fund broadly the very best proposals across all relevant disciplines and as such focus areas can include basic, preclinical, clinical research and clinical care. The award period is two years with a 1-year interim renewal to occur upon successful completion of the year one research goals. Stipends are $50,000 per year, with the intention that all funds are strictly used for direct support of the grantee or their research program.

The foundation maintains the highest standards and thus no minimum quota of grants are made in any one year. However, given the outstanding quality of candidates requesting support since the founding of the Terri Brodeur Breast Cancer Foundation, the committee seeks to fund as many meritorious fellowships as is financially possible each year. As such, it is our expectation that the grant administrators and mentors at each institution proactively carry out prescreening of proposals or applicants as is appropriate. We ask that this occurs as an active process as it greatly enables the administration of the funds. We are happy to provide additional guidance on this last point as may be needed.

Scientific Advisory Board Members

Nicholas Saccomano, PhD 
Chair – Chief Scientific Officer, Senior VP, Pfizer Boulder Research and Development

John LaMattina, PhD 
Co-Chair – Former President, Pfizer Global Research and Development

Michael Garabedian, PhD 
Professor and Course Director, New York University Medical Center

Susan Logan, PhD
Associate Professor, New York University Medical Center

Michael Morin, PhD
President and Chief Scientific Officer Immunome

TBBCF Research Grant Recipients

Click here for a listing of publications with acknowledgements of support from the Terri Brodeur Breast Cancer Foundation. Click here for a listing of grant recipient abstracts – 2007-2020.

Looking to make a donation?